Early detection of pancreatic cancer: Where are we now and where are we going? (Q39152619)

9 September 2017

title

Early detection of pancreatic cancer: Where are we now and where are we going? (English)

1 reference

9 September 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Bin Zhou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jian-Wei Xu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Yu-Gang Cheng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jing-Yue Gao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

San-Yuan Hu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Lei Wang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

27 February 2017

1 reference

International Journal of Cancer

9 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

231-241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

cites work

Cancer statistics, 2016

1 reference

Pancreatic Adenocarcinoma

21 January 2018

1 reference

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

21 January 2018

1 reference

Pancreatic cancer stem cells: new insight into a stubborn disease

21 January 2018

1 reference

Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society

21 January 2018

1 reference

Screening for pancreatic cancer: why, how, and who?

21 January 2018

1 reference

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

21 January 2018

1 reference

High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening

21 January 2018

1 reference

Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters

21 January 2018

1 reference

Early detection and prevention of pancreatic cancer: is it really possible today?

21 January 2018

1 reference

Modifiable and non-modifiable risk factors for pancreatic cancer: A review

21 January 2018

1 reference

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.

21 January 2018

1 reference

Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

21 January 2018

1 reference

Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography.

21 January 2018

1 reference

Diagnostic value of diffusion-weighted magnetic resonance imaging compared with fluorodeoxyglucose positron emission tomography/computed tomography for pancreatic malignancy: a meta-analysis using a hierarchical regression model

21 January 2018

1 reference

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

21 January 2018

1 reference

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

21 January 2018

1 reference

Exome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Whole genomes redefine the mutational landscape of pancreatic cancer

21 January 2018

1 reference

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

21 January 2018

1 reference

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

21 January 2018

1 reference

NOP14 promotes proliferation and metastasis of pancreatic cancer cells

21 January 2018

1 reference

TUFT1 regulates metastasis of pancreatic cancer through HIF1-Snail pathway induced epithelial-mesenchymal transition

21 January 2018

1 reference

Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer

21 January 2018

1 reference

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

21 January 2018

1 reference

Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier

21 January 2018

1 reference

Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.

21 January 2018

1 reference

KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis

21 January 2018

1 reference

Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer

21 January 2018

1 reference

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study

21 January 2018

1 reference

ATM mutations in patients with hereditary pancreatic cancer

21 January 2018

1 reference

Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers

21 January 2018

1 reference

A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers

21 January 2018

1 reference

High-frequency aberrantly methylated targets in pancreatic adenocarcinoma identified via global DNA methylation analysis using methylCap-seq.

21 January 2018

1 reference

Novel methylation biomarker panel for the early detection of pancreatic cancer

21 January 2018

1 reference

Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer

21 January 2018

1 reference

The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma

21 January 2018

1 reference

miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review

21 January 2018

1 reference

Early detection of sporadic pancreatic cancer: summative review

21 January 2018

1 reference

MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions

21 January 2018

1 reference

Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma.

21 January 2018

1 reference

Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer

21 January 2018

1 reference

A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile

21 January 2018

1 reference

Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma

21 January 2018

1 reference

Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: A Multicenter Study.

21 January 2018

1 reference

Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study

21 January 2018

1 reference

MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls.

21 January 2018

1 reference

Circulating RNAs as new biomarkers for detecting pancreatic cancer

21 January 2018

1 reference

LncRNAs in pancreatic cancer

21 January 2018

1 reference

Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer

21 January 2018

1 reference

Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer

21 January 2018

1 reference

Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments

21 January 2018

1 reference

Circulating mutant DNA to assess tumor dynamics

21 January 2018

1 reference

Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.

21 January 2018

1 reference

Detection of circulating tumor DNA in early- and late-stage human malignancies

21 January 2018

1 reference

Liquid biopsies: genotyping circulating tumor DNA

21 January 2018

1 reference

Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients

21 January 2018

1 reference

Follow-up study of K-ras mutations in the plasma of patients with pancreatic cancer: correlation with clinical features and carbohydrate antigen 19-9.

21 January 2018

1 reference

Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer

21 January 2018

1 reference

Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA

21 January 2018

1 reference

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer

21 January 2018

1 reference

Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver

21 January 2018

1 reference

Tumour exosome integrins determine organotropic metastasis.

21 January 2018

1 reference

Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites

21 January 2018

1 reference

Pancreatic cancer screening using a multiplatform human serum metabolomics system.

21 January 2018

1 reference

Pancreatic cancer, inflammation, and microbiome

21 January 2018

1 reference

Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study

21 January 2018

1 reference

Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer

21 January 2018

1 reference

Characterization of the salivary microbiome in patients with pancreatic cancer

21 January 2018

1 reference

Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags

21 January 2018

1 reference

Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics

21 January 2018

1 reference

The Role of CTCs as Tumor Biomarkers

21 January 2018

1 reference

Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids

21 January 2018

1 reference

Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis

21 January 2018

1 reference

Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma

21 January 2018

1 reference

Tumor cell metabolism: cancer's Achilles' heel

21 January 2018

1 reference

Circulating Metabolites and Survival Among Patients With Pancreatic Cancer

21 January 2018

1 reference

Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats

21 January 2018

1 reference

Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

21 January 2018

1 reference

Serum metabolomic analysis of pancreatic cancer--response

21 January 2018

1 reference

Transcriptome meets metabolome: hierarchical and metabolic regulation of the glycolytic pathway

21 January 2018

1 reference

Risk factors for pancreatic cancer: a summary review of meta-analytical studies

21 January 2018

1 reference

Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis.

21 January 2018

1 reference

Study Links Periodontal Disease Bacteria to Pancreatic Cancer Risk.

21 January 2018

1 reference

Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models

21 January 2018

1 reference

Mutant-Enriched PCR and Allele-Specific Hybridization Reaction to Detect K-ras Mutations in Stool DNA: High Prevalence in a Large Sample of Older Adults

21 January 2018

1 reference

Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates

21 January 2018

1 reference

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

21 January 2018

1 reference

Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma

21 January 2018

1 reference

Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia

21 January 2018

1 reference

Proteomics analysis of bodily fluids in pancreatic cancer

21 January 2018

1 reference

Role of pancreatic cancer-derived exosomes in salivary biomarker development

21 January 2018

1 reference

Salivary MicroRNA in Pancreatic Cancer Patients.

21 January 2018

1 reference

Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies

21 January 2018

1 reference

Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.

21 January 2018

1 reference

Pathology, genetics and precursors of human and experimental pancreatic neoplasms: An update

21 January 2018

1 reference

Preclinical models of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.30670

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28240774%20AND%20SRC:MED&resulttype=core&format=json